Literature DB >> 16707922

Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.

Stephen Swenson1, Fritz Costa, William Ernst, Gary Fujii, Francis S Markland.   

Abstract

Disintegrins are soluble peptides found in snake venom. They bind to Arg-Gly-Asp (RGD)-responsive integrins with high affinity (nM range) and block integrin function. Contortrostatin (CN), the disintegrin from southern copperhead venom, is a homodimer with a molecular weight of 13,500. Each chain contains 65 amino acids with an Arg-Gly-Asp motif. CN has anti-invasive and anti-adhesive activity on tumor cells and endothelial cells in vitro, and binds to integrins alphavbeta3, alphavbeta5, and/or alpha5beta1. In vivo studies using the human metastatic breast cancer cell line MDA-MB-435, in an orthotopic xenograft model in nude mice, revealed that CN has potent anti-tumor and anti-angiogenic activity. Recent studies have employed an intravenous liposomal delivery procedure. Liposomal delivery of CN has also been shown to provide effective in vivo anti-tumor and anti-angiogenic activity in a human ovarian cancer animal model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16707922     DOI: 10.1159/000092418

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  20 in total

1.  Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-2.

Authors:  Jei-Ming Peng; Yee-Hsiung Chen; Shao-Wen Hung; Ching-Feng Chiu; Ming-Yi Ho; Yi-Jen Lee; Tsung-Ching Lai; Michael Hsiao; Chi-Ming Liang; Shu-Mei Liang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Evaluation of cytotoxic activities of snake venoms toward breast (MCF-7) and skin cancer (A-375) cell lines.

Authors:  Michael J Bradshaw; Anthony J Saviola; Elizabeth Fesler; Stephen P Mackessy
Journal:  Cytotechnology       Date:  2014-11-19       Impact factor: 2.058

3.  The mojastin mutant Moj-DM induces apoptosis of the human melanoma SK-Mel-28, but not the mutant Moj-NN nor the non-mutated recombinant Moj-WN.

Authors:  Agustin I Seoane; Victoria L Tran; Elda E Sanchez; Stephanie A White; Jason L Choi; Brandon Gaytán; Natalie Chavez; Steven R Reyes; Carla J Ramos; Luan H Tran; Sara E Lucena; Maria Sugarek; John C Perez; Stephanie A Mandal; Shervin Ghorab; Alexis Rodriguez-Acosta; Branden K Fung; Julio G Soto
Journal:  Toxicon       Date:  2010-04-14       Impact factor: 3.033

4.  Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells.

Authors:  Takele Teklemariam; Agustin I Seoane; Carla J Ramos; Elda E Sanchez; Sara E Lucena; John C Perez; Stephanie A Mandal; Julio G Soto
Journal:  Toxicon       Date:  2011-01-19       Impact factor: 3.033

Review 5.  Biological Effects of Animal Venoms on the Human Immune System.

Authors:  Zharick Avalo; María Claudia Barrera; Manuela Agudelo-Delgado; Gabriel J Tobón; Carlos A Cañas
Journal:  Toxins (Basel)       Date:  2022-05-16       Impact factor: 5.075

6.  Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth.

Authors:  Meghan C Brown; Izabela Staniszewska; Luis Del Valle; George P Tuszynski; Cezary Marcinkiewicz
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

Review 7.  Snake venom disintegrins and cell migration.

Authors:  Heloisa S Selistre-de-Araujo; Carmen L S Pontes; Cyntia F Montenegro; Ana Carolina B M Martin
Journal:  Toxins (Basel)       Date:  2010-10-29       Impact factor: 4.546

8.  The anti-cancer potency and mechanism of a novel tumor-activated fused toxin, DLM.

Authors:  Dejun Sun; Miaonan Sun; Wenhe Zhu; Zhiding Wang; Yuefei Li; Jie Ma
Journal:  Toxins (Basel)       Date:  2015-02-04       Impact factor: 4.546

9.  Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.

Authors:  Julie A Sharp; Sonia L Mailer; Peter C Thomson; Christophe Lefèvre; Kevin R Nicholas
Journal:  Mol Cancer       Date:  2008-01-07       Impact factor: 27.401

10.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.